Continuous ambulatory peritoneal dialysis: pharmacokinetics and clinical outcome of paclitaxel and carboplatin treatment.

Cancer Chemotherapy and Pharmacology
Joan B HeijnsWalter J Loos

Abstract

Administration of chemotherapy in patients with renal failure, treated with hemodialysis or continuous ambulatory peritoneal dialysis (CAPD) is still a challenge and literature data is scarce. Here we present a case study of a patient on CAPD, treated with weekly and three-weekly paclitaxel/carboplatin for recurrent ovarian cancer. During the first, second and ninth cycle of treatment, blood, urine and CAPD samples were collected for pharmacokinetic analysis of paclitaxel and total and unbound carboplatin-derived platinum. Treatment was well tolerated by the patient. No excessive toxicity was observed and at the end of treatment she was in a complete remission. The plasma pharmacokinetics of paclitaxel were unaltered compared to historical data, with neglectable urinary and CAPD clearance. In contrast, the pharmacokinetics of carboplatin were altered, with doubled half-lives compared to patients with normal renal function. Of the administered carboplatin dose, up to 20% was cleared via the dialysate, while only up to 8% was cleared via the urine. Paclitaxel and carboplatin can be safely administered to patients with chronic renal failure on CAPD. For paclitaxel the generally applied dose can be administered, and although for ca...Continue Reading

References

Jan 1, 1976·Nephron·D W Cockcroft, M H Gault
Nov 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A H CalvertE Wiltshaw
Jan 1, 1997·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·S SuzukiT Matsuo
Oct 7, 1997·Clinical Pharmacokinetics·S B Duffull, B A Robinson
Jan 29, 1999·Cancer Chemotherapy and Pharmacology·M H WooM V Relling
Aug 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R S Go, A A Adjei
Jan 7, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F M MuggiaJ M Small
Aug 30, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J P NeijtH C van Houwelingen
Mar 10, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·N. JeyabalanF. Moens
Dec 26, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H GelderblomA Sparreboom
Jan 12, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hans GelderblomAlex Sparreboom
Jan 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carolien H SmorenburgJaap Verweij
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert F OzolsUNKNOWN Gynecologic Oncology Group
Nov 25, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C MitaR Bugat
Dec 18, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A InoueT Nukiwa
Mar 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marco B PoleeAte van der Gaast
Dec 14, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M E L van der BurgJ Verweij
Dec 24, 2005·Clinical Oncology : a Journal of the Royal College of Radiologists·C W Lee, J Fabbro
Apr 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Walter J LoosJaap Verweij
Jun 16, 2006·Cancer Biology & Therapy·Frederike K EngelsJaap Verweij
Jul 26, 2006·World Journal of Gastroenterology : WJG·Susumu KawateYasuo Morishita
Nov 7, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Corine EkhartJos H Beijnen
Feb 21, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Y F LiJ J Kavanagh
May 15, 2007·Gynecologic Oncology·Isabelle CadronIgnace Vergote

❮ Previous
Next ❯

Citations

Jan 1, 2010·International Journal of Nephrology and Renovascular Disease·J VerwimpK Bulté
Jan 24, 2014·Medical Oncology·Achuta K GuddatiCreticus P Marak
Apr 8, 2014·Medical Oncology·Achuta K GuddatiCreticus P Marak
Feb 19, 2009·Veterinary and Comparative Oncology·J L IntileJ J Wakshlag
Jun 29, 2011·Proceedings of the National Academy of Sciences of the United States of America·Ying-Chih LiuChi-Huey Wong
Aug 21, 2020·Cancer Chemotherapy and Pharmacology·A Laura NijstadAlwin D R Huitema

❮ Previous
Next ❯

Methods Mentioned

BETA
hysterectomy

Software Mentioned

WinNonLin

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
N JanusV Launay-Vacher
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Ingrid VandenputFrederic Amant
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Takeshi HisamatsuTadashi Kimura
© 2021 Meta ULC. All rights reserved